MICROBIOMEUK LIMITED
Company number 03824350 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Credit Analysis: MICROBIOMEUK LIMITED
1. Credit Opinion: DECLINE
Reasoning: This entity presents an unacceptable credit risk for any meaningful facility. The company has negligible financial substance, with net assets of just £57 and no visible revenue generation. The balance sheet contains no cash, no fixed assets, and only £58 in prepayments as its sole asset. There is no capacity to service debt obligations from existing resources, and no trading income is evident from the filed accounts. The recent name change from property development to "MicrobiomeUK" suggests a strategic pivot, but this appears aspirational rather than operational given the complete absence of financial activity.
2. Financial Strength
Balance Sheet Position: Extremely Weak
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Assets | £57 | £57 | £58 |
| Total Liabilities | £1 | £1 | N/A |
| Share Capital | £2 | £2 | N/A |
| Retained Earnings | £55 | £55 | N/A |
- The company has accumulated only £55 in retained earnings over its entire 25-year history since incorporation in 1999
- No fixed assets are held — unusual for a company previously operating in property letting/development
- The sole asset is £58 in prepayments, suggesting advance payments for services not yet received rather than trading receivables
- Shareholders' funds of £57 provide no meaningful capital cushion
- No cash balances are reported on the balance sheet
Ownership Structure Concern: Two corporate PSCs (Secured Property Developments Plc and Mollyroe Plc) both claim ownership of more than 75% of shares. This is contradictory and either represents a filing error or indicates a complex share class structure requiring clarification. Either scenario raises governance concerns.
3. Cash Flow Assessment
Liquidity: Critically Insufficient
- Current Assets: £58 (entirely prepayments)
- Current Liabilities: £1 (taxation and social security only)
- Working Capital: £57
The working capital position appears positive in ratio terms, but this is misleading. The prepayments of £58 represent amounts already paid out for future services — they are not readily convertible to cash. No trade debtors exist, indicating no revenue-generating activity. No cash is held. The company has no operating cash flow visibility as the Profit & Loss account has not been delivered to the registrar (permitted under s.444(5A) for small companies).
Absence of Trading Evidence: The accounts show no turnover, no cost of sales, no operating activities. The company appears to be operating as a dormant or near-dormant shell despite its "Active" status and stated principal activity of "Property Letting."
4. Monitoring Points
If any facility were ever to be considered (which would require fundamental changes to the business), the following would require close monitoring:
-
Trading Activity Commencement: Evidence that the name change to "MicrobiomeUK" reflects actual operational activity in the biotech/health sector, with corresponding revenue generation
-
Cash Generation: Bank statements demonstrating regular trading inflows and the ability to generate operating cash flow sufficient to cover debt service
-
Ownership Clarification: Resolution of the contradictory PSC declarations — two entities cannot each own >75% of ordinary share capital without explanation of share class structures
-
Related Party Transactions: Given the corporate PSCs, understanding the nature and extent of inter-company obligations is essential. The prepayments of £58 may represent amounts due to connected entities
-
Director Backgrounds: Both directors are Irish nationals. Further due diligence on their other directorships and business interests would be prudent, particularly regarding Secured Property Developments Plc and Mollyroe Plc's financial standing
-
Strategic Direction: The May 2024 name change from "Secured Property Developments (Scarborough) Limited" to "MicrobiomeUK Limited" represents a significant business pivot. Evidence of a credible business plan, funding arrangements, and management capability in the new sector would be required